The synaptosomal-associated protein of 25 kDa gene (SNAP25) has been suggested as a genetic susceptibility factor in attention-deficit hyperactivity disorder (ADHD) based on the mouse strain coloboma. This strain is hemizygous for the SNAP25 gene and displays hyperactivity that responds to dextroamphetamine, but not to methylphenidate. Previously, we reported association of SNAP25 and ADHD using two polymorphisms. To further investigate this gene, we screened the exons for DNA variation and genotyped ten additional polymorphisms in an expanded sample of families from Toronto and a second sample of families collected in Irvine, CA. Significant results were observed in the Toronto sample for four markers, although not in the Irvine sample. The paper discusses the possible influence of the selection criteria on these differential results. The Irvine sample selected subjects that met the DSM-IV combined subtype diagnosis, whereas the Toronto sample included all subtypes. Analysis of the DSM-IV subtypes in the Toronto sample indicated that the differential results were not attributable to ADHD subtype. Differences in ethnicity, differential medication response, and other clinical characteristics of the samples cannot be ruled out at this time. Quantitative analysis of the dimensions of hyperactivity/impulsivity and inattention in the Toronto sample found that both behavioral traits were associated with SNAP25. Our findings continue to support SNAP25 in the susceptibility to ADHD. Keywords: genetics; SNAP25; attention-deficit hyperactivity disorder; transmission disequilibrium test; linkage; polymorphism; ADHD The synaptosomal-associated protein of 25 kDa (SNAP25) is an integral component of the vesicle docking and fusion machinery mediating regulated release of neurotransmitters 1 and is implicated in axonal growth and synaptic plasticity.
The synaptosomal-associated protein of 25 kDa (SNAP25) is an integral component of the vesicle docking and fusion machinery mediating regulated release of neurotransmitters 1 and is implicated in axonal growth and synaptic plasticity. 2 The gene for SNAP25 is suggested as a candidate gene for attention-deficit hyperactivity disorder (ADHD) based on the mouse mutant strain coloboma. This strain is hemizygous for the deletion of the SNAP25 gene, resulting in a 50% reduction in the expression of the gene throughout the central nervous system. 3 The coloboma strain displays significantly more spontaneous hyperactivity than control littermates and in some cases up to 10 times greater activity. 3 The mechanisms underlying the behavior of these mice appear to be the result of dysregulation in the controlled release of neurotransmitters in select brain regions; particularly, glutamate content and release in the neocortex is reduced, and dopamine utilization is decreased while norepinephrine concentration is increased within striatal structures. 4, 5 Another interesting finding of the coloboma strain is that administration of dextroamphetamine, but not methylphenidate, reduces locomotor activity. 6 The differential effect of dextroamphetamine over methylphenidate is likely due to the different presynaptic mechanisms of these two agents. Both agents increase synaptic catecholamines through the blockade of the dopamine and norephinephrine transporters, but dextroamphetamine also increases the release of these neurotransmitters.
The mutation in the coloboma mouse involves a 2 cM deletion of chromosome 2p and comprises several genes including SNAP25. The coloboma strain shows characteristic's other than hyperactivity, 3 but the specific role of SNAP25 in the hyperactive phenotype has been evidenced in the amelioration of the hyperactivity when the deleted SNAP25 gene is replaced with a transgene of SNAP25. 6 Despite the strong evidence of a connection between SNAP25 and the expression of hyperactivity in the coloboma mouse, a recent study of another mouse line hemizygous for the SNAP25 gene did not display hyperlocomotor activity and exhibited a blunted response to stimulating doses of D-amphetamine. 7 The most likely explanation for the differences in the behavior of these two mouse lines is the different genetic background of the mice used, implicating the existence of modifier genes influencing the hyperlocomotion phenotype. The finding paves the way for the identification of these genes using crosses of the mouse lines used.
A number of studies have shown an association between SNAP25 and ADHD in humans. Previously, we investigated the relationship of SNAP25 with ADHD using two polymorphisms that we identified in the 3 0 untranslated region in a sample of 97 nuclear families collected in Toronto, Ontario. 8 We found a trend for association with the alleles of one of the polymorphisms, and significant evidence for association with one of the haplotypes of the two 3 0 polymorphisms. Further support for this gene as a susceptibility factor in ADHD has been recently reported in other samples; however, the alleles and polymorphisms associated with ADHD were not consistent across studies. [9] [10] [11] [12] In this study, we sought to further investigate this gene using an expanded sample collected in Toronto (186 families with 234 ADHD children) and an independent sample of 99 families with 102 affected children collected in Irvine, CA. We extended the previous investigation by screening all the coding exons for additional DNA variants. We examined the relationship of markers in this gene to ADHD as a categorical trait and with the specific behavioral traits of hyperactivity/impulsivity and inattention as separate quantitative dimensions.
Materials and methods

Diagnostic criteria
Subjects from The Hospital for Sick Children, Toronto Methods of assessment, characteristics of the subjects, and inclusion and exclusion criteria for the study have been previously described, including the instruments used to collect information for diagnosis of ADHD and comorbid conditions, and to assess academic and language skills. 8, [13] [14] [15] [16] Probands and their siblings were included if they were between 7 and 16 years old, and met DSM-IV criteria for one of the three ADHD subtypes (inattentive, hyperactiveimpulsive, or combined). Of the cases that were used in this study, 58% of the children were of the combined subtype, 14% were of the hyperactive/ impulsive subtype, and 26% were of the primarily inattentive subtype. The subtype could not be determined on 2% of the children. Children were free of medication for a minimum of 24 h before their assessment. This protocol was approved by The Hospital for Sick Children's Research Ethics Board, and informed written consent and assent was obtained for all participants.
Subjects from the University of California Irvine Child Development Center Probands identified at the University of California (UC) Irvine Child Development Center in Irvine, CA have been previously described. 17, 18 Briefly, subjects were recruited from clinical trials with a diagnosis of combined subtype ADHD by DSM-IV criteria confirmed by a structured interview. 19 To be included in the genetic study, a clinical response to methylphenidate was required, and severe comorbid disorder that required nonstimulant treatment was not allowed. This protocol was approved by the University of California Institutional Review Board and written informed consent and assent were obtained from all participants prior to involvement in any study procedure.
Families
We genotyped DNA from 102 subjects diagnosed with ADHD from Irvine and 234 subjects from Toronto, who were either probands or affected siblings in small nuclear families. The Irvine sample consisted of 99 nuclear families composed of 64 probands with both parents genotyped and 35 families with a single parent genotyped. Three siblings who were also participating in the clinical trial and who met the same criteria for ADHD were included in this study.
The Toronto sample consisted of 186 families with an ADHD proband. Of these, 43 families had genotypes available for a single parent and the remainder had DNA genotyped for both parents In all 48 affected siblings were included in the analysis. The results of the MnlI (rs3746544) and DdeI (rs1051312) polymorphisms reported here for the Toronto sample included the results from the previously reported 97 families.
Polymorphism detection and marker genotyping DNA sequence variants were identified using single strand conformational polymorphism (SSCP) analysis 20 or through public databases (NCBI; http:// www.ncbi.nlm.nih.gov/SNP/index.html, Applied Biosystems, Assays-on-Demand s ; https://www. appliedbiosystems.com/). For SSCP analyses, primers were designed to screen the entire exon including, as much as possible, the exon/intron boundaries. We were able to design primers that screened from 6 to 167 bp of the intron sequence for each of the PCR products. We also screened 370 bp of the region 5 0 to exon 1 by resequencing. For SSCP analysis, 2 microliters (ml) of PCR product was diluted in 24 ml of SSCP loading dye (98% formamide 0.1% SDS, 10 mM EDTA, 0.1% bromphenol blue, 0.1% xylene SNAP25 and ADHD Y Feng et al cyanole), and denatured at 951C for 2 min. Samples were cooled on ice and subjected to electrophoresis at a constant voltage of 200 V on 4-20% gradient nondenaturing polyacrylamide TBE gels (Novex, La Jolla, CA, USA). The SSCP bands were visualized by silver staining. A minimum of 24 probands were screened for each PCR product. Gels were run at 20, 10 or 41C to increase the sensitivity to detect conformational polymorphisms. We cloned PCR products from individuals with bands with different mobilities using the TA cloning kit (Invitrogen, Carlsbad, CA, USA). After comparing the SSCP pattern of the clones with the SSCP pattern of the individual that the clones were derived from, we sequenced several clones with different mobilities.
The genotyping assays for the two restriction enzyme polymorphisms, MnlI (rs3746544) and DdeI (rs1051312), have been previously described. 8 The remaining polymorphisms were genotyped using the 5 0 nuclease assay (TaqMan s ), on an ABI 7900 (Applied Biosystems, Foster City, CA, USA) using either commericially available probes and primers (Assays-by-Demand s , Applied Biosystems) or probes and primers designed by us for this study. PCR reactions, total volume of 10 ml, contained 30 ng of genomic DNA, 10 mmol of TaqMan s Universal PCR Master Mix (Applied Biosystems), and 0.25 ml of allelic discrimination mix (Applied Biosystems) which contained 36 mM of each primer and 8 mM of each probe. The thermal cycling conditions were 501C for 2 min, 951C for 10 min, and then 40 cycles of 921C for 15 s and 1 min at the annealing temperature that was between 58 and 601C for each system. Each 96-well plate contained two negative controls. Plates were then read on the ABI 7900HT Sequence Detection System using the allelic discrimination end-point analysis mode of the software package version 2.0 (Applied Biosystems).
Statistical analysis
The transmission of the alleles for the transmission disequilibrium test (TDT) was calculated using the extended TDT (ETDT) program, 21 and the transmission of the haplotypes was analyzed with the TRANSMIT program using the robust estimator option. 22 Linkage disequilibrium (LD) between the markers was estimated with the program ldmax, available in the GOLD software package (http:// www.sph.umich.edu/csg/abecasis/GOLD/download/ index.html). All polymorphisms were in HardyWeinberg equilibrium. The results were not corrected for multiple tests as the markers are in LD, and therefore these are not independent tests. Currently there is no consensus on how this correction should be done with markers in strong LD.
Analyses of behavioral dimensions were carried out using a quantitative TDT as implemented in the FBAT program using an additive model. 23 An offset of 0.8 was used derived from population-based mean scores. In these quantitative trait TDT analyses, the transmission of the alleles was examined in relation to parent and teacher ratings of DSM-IV inattentive and hyperactive/impulsive symptom counts. Nine possible symptoms for each dimension, as specified by the DSM-IV, were tallied for parents and teachers separately. Parent and teacher ratings were carried out separately to account for potential rate differences. 24 
Results
Based on our previous linkage finding for ADHD and the SNAP25 gene, we continued to screen for additional polymorphisms for genetic analysis as well as to search for DNA variants that may contribute to the phenotype. Using SSCP analysis we identified in one proband of the 48 screened, a C to A change located 34 bp 5 0 to the start codon. Because this DNA change was found in only one of the 48 probands screened, we did not pursue this DNA variant further as it would not be informative for genetic analysis. The second DNA variant (rs362998) was found in approximately 5% of the sample screened and was identified as a C to T change at position 330 in the mRNA sequence that does not change the amino acid (aspartic acid) at that position (Asp110Asp). The third DNA variant identified was located in intron 5, 538 bp 5 0 to exon 6 and is identified as rs362987 in the NCBI database. We identified an additional eight polymorphisms from public databases that were genotyped in our sample. The locations of the polymorphisms used in this study are shown in Figure 1 . The allele frequencies for the polymorphisms in the parental chromosomes are shown in Table 1 probands for each of the polymorphisms in both samples. We tested for biased transmission of the alleles at each polymorphism using the TDT test calculated with the ETDT program ( Table 1 ). The TDT test was not significant for any of the alleles of the polymorphisms in the Irvine sample. In the Toronto sample there was significant evidence for biased transmission of the alleles of four polymorphisms, located in intron 3 (rs6039806), intron 4 (rs362549), intron 5 (rs362987), and exon 6 (rs362998). Haplotype analyses did not reveal any association more informative than single-marker analysis in the Toronto sample and no significant association was identified in the Irvine sample. The degree of LD between the polymorphisms is shown in Tables 2 (D  0 ) and Table 3 (r   2   ) . We observed strong disequilibrium as measured by D 0 in both samples across the gene when examining consecutive markers with the exception of two regions where the LD was reduced. The first was between the marker rs1889189, located 5 0 to the first exon and the rs362569 marker located approximately 50 kb 3 0 to rs1889189 in intron 1 (D 0 ¼ 0.608 and 0.526 for Irvine and Toronto, respectively). The other region with reduced LD was between intron 7 (rs363006) and the three markers located approximately 7 kb away in the 3 0 untranslated region (D 0 less than 0.501 in both samples). When comparing between the two samples, LD between markers was similar for the majority of regions with a few exceptions. Most notable is that between markers C___2488338_10 located in intron 3 and rs3746544 (MnlI) in the 3 0 untranslated region where the D 0 in the Irvine sample was 1.000 but 0.179 in the Toronto sample. In contrast, the LD was stronger in the Toronto sample, between rs36006 and rs1051312 (DdeI), than in the Irvine sample (0.385 vs 0.069) Because the Irvine sample only included subjects with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, DSM-IV 25 combined-type subtype, we analyzed the four most informative markers in the Toronto sample according to subtype (Table 4) . We observed no significant evidence for biased transmission of the alleles in the inattentive or hyperactive/impulsive only subtypes. However, we observed significant evidence for biased transmission of the alleles in the combined subtype sample for all four markers.
To investigate the potential relationship of specific behavioral traits with SNAP25, we looked at the hyperactive/impulsive and inattentive dimensions of ADHD using quantitative analysis for parent-and teacher-rated symptoms for the four significant polymorphisms in the Toronto sample (Table 5 ). A significant relationship was found for higher parentand higher teacher-rated symptom scores for both inattention and hyperactivity/impulsivity for the markers in introns 3-5, and exon 6. 
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Discussion
Our goal for this study was to further examine the relationship of SNAP25 and the ADHD phenotype and to search for DNA variants in the gene contributing to ADHD. Our screening of the coding regions of this gene did not identify any changes that would predict a change in function. Despite our use of three temperatures for screening the SSCP to increase sensitivity, it is possible that we missed detection of a DNA change. However, another study using denaturing high-performance liquid chromatography, a much more sensitive technique, also did not find any additional coding region changes. 12 We also screened 370 bp of the region 5 0 to exon 1 and did not find any DNA changes. These findings, taken together, suggest that the DNA change(s) contributing to ADHD must be in the regulatory regions of the gene, and these regulatory regions have not yet been delineated.
We tested 10 new markers in an independent sample of families as well as an expanded sample Table 5 Quantitative trait analyses of parent-and teacher-reported symptoms of inattention and hyperactivity/impulsivity behavior dimensions from the DSM-IV of the SNAP-25 polymorphisms in the Toronto ADHD sample There are several possible explanations, outside of type I error, to explain the differential results between the Toronto and Irvine families with respect to SNAP25, primarily having to do with the differences between the two samples. The disparity in the TDT results between the samples could be due to differences in the way the two samples were selected, such as differences in the diagnostic methods, and/or the inclusion and exclusion criteria. The Irvine sample included only the DSM-IV combined type, whereas the Toronto sample included all three subtypes; however, the results do not support that DSM-IV subtype is a contributing factor in the differential results between the two samples. Analysis of subtypes in the Toronto sample showed significant results only in the combined subtype sample. While it would appear from the division of the subjects in this way that the gene is only contributing to the combined subtype, this may be misleading because the sample size for the inattention only and hyperactive/impulsive subtypes is much smaller. Furthermore, when the behavioral dimensions of inattention and hyperactivity/impulsivity were investigated as quantitative traits, both dimensions were found to be independently associated with SNAP25 polymorphisms. This result supports the involvement of SNAP25 in both behavioral dimensions of the ADHD phenotype.
Another key difference between the samples was the requirement of the Irvine sample that a clinical response to methylphenidate was required in all subjects. While this could not be directly evaluated in the present study, the potential contribution is considered. In the coloboma mouse model, the differential response to dextroamphetamine (a drug that increases the release of dopamine and norepinephrine and blocks its re-uptake) and methylphenidate (a drug that primarily blocks dopamine and norephinephrine re-uptake) may be due to the differences in presynaptic mechanisms of these two medications. Blockade of these transporters alone may not be sufficient to raise synaptic catecholamine levels if neurotransmitter release is reduced due to decreased levels of the SNAP25 protein. An increase in the release of neurotransmitters, as well as blockage of the dopamine transporters, may be required to increase synaptic levels of catecholamines resulting in a change in locomotor activity. Based on the finding of differential response to dextroamphetamine in the coloboma mouse, it could be hypothesized that individuals possessing SNAP25 risk allele(s) will have increased hyperactivity and have a poor response to methylphenidate. Given that the estimates for methylphenidate response in ADHD are approximately 70-75%, then this gene would have to have a significant contribution to the genetic susceptibility to ADHD in the estimated 25-30% that would be poor responders in a given sample to be detected. In the current Toronto sample this would be approximately 59 to 70 of the individuals and thus would be possible to detect. In smaller samples, it would be unlikely to be detected.
Ethnic differences between the two samples could contribute to the differences in the results and we cannot rule this out at this time. The Irvine sample was composed of greater than 85% of families that describe themselves as of European Caucasian descent. About 13% of the sample reported a Hispanic or Native American grandparent, and 2% reported a black American grandparent, compared to 95% of the Toronto sample that described themselves as European Caucasian with the remainder being of mixed ethnicity mainly from the Caribbean. This gene may not be contributing to ADHD susceptibility in all ethnic groups, or DNA changes may have occurred on different haplotypes in different ethnic groups preventing the detection of an association or creating an association with different alleles and haplotypes. In the Irvine sample, there were trends for biased transmission of the alleles at a number of the markers; however, the allele transmission was always in the opposite direction of that observed in the Toronto sample. This could indicate the presence of different risk alleles in the Irvine sample. Three previous studies of ADHD of the two 3 0 UTR polymorphisms of SNAP25 reported association; however, the studies observed association with different alleles, 9-12 further suggesting the possibility of different risk alleles in different populations. Further, in our previous finding in the smaller Toronto sample, we observed a trend for biased transmission of alleles at the rs1051312 (DdeI) polymorphism and significant evidence for biased transmission of the haplotypes of this marker and the rs3746544 (MnlI) marker that was no longer evidenced in the expanded sample. Our observation in this study of different degrees of LD in the two samples between some of the markers indicates that different samples may show different results using these markers. Most notable is the difference in LD between the MnlI marker in the 3 0 UTR and the C__2488338_10 marker located in intron 3 in the Toronto (D 0 ¼ 0.179) compared to the Irvine sample (D 0 ¼ 1.000). Additional studies, including dense marker genotyping in areas of reduced and variable LD in ADHD, as well as population samples collected worldwide are necessary to determine if ethnicity or other clinical features of the sample are factors contributing to these differences and these studies are planned.
Another consideration is the smaller sample size of the Irvine sample compared to the Toronto sample. The reduced power of the sample could result in failure to observe an association. However, as stated above, the observation was a trend for biased transmission of alleles, but always in the opposite direction to the Toronto sample, suggesting that the sample size alone cannot explain these discrepant results.
This study included quantitative trait analyses of the behavioral dimensions of inattention and hyperactive/impulsivity. The results were consistent across risk alleles and informant, such that both behavioral traits were associated to the same alleles identified in the categorical analysis (introns 3-5, and exon 6). This result are is contrast to what one might expect based strictly on the coloboma mouse model, which would predict a hypothesis for increased hyperactivity. This study provides evidence that in humans SNAP25 is associated with the inattention phenotype as well as the hyperactivity/impulsivity phenotype of ADHD. A limitation of the coloboma mouse as a model for ADHD is the focus on the behavioral phenotype only. Inattention, a hallmark attribute of the disorder in humans, has not been directly assessed in the coloboma mouse and a focus on behavioral hyperactivity is generally a limitation of animal models for ADHD.
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SNAP25 has been connected with deficits in information processing and learning in the coloboma mouse line, which could broadly be linked to attention processes in humans. 27 The relationship of attention, learning, and cognition with SNAP25 requires further investigation in animal models and in future research with humans.
